NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Observational Study of VYKAT™ XR in Patients With Prader-Willi Syndrome

Enrolling By InvitationN/A

Sponsor: Soleno Therapeutics, Inc.

Conditions: Prader-Willi Syndrome

Interventions: VYKAT XR

Countries: United States

Prospective observational study developed to generate more evidence of the safety profile, clinical characteristics and outcomes of patients with PWS treated with VYKAT XR.

Eligibility overview

Sex: ALL

Age: 4 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Patients currently receiving or initiating treatment with VYKAT XR, including patients who previously received DCCR or are transitioning from DCCR to VYKAT XR in the context of a prior DCCR clinical trial.
* Patients and/or caregivers must provide written informed consent.

Locations (24)

Phoenix, Arizona, United States
Los Angeles, California, United States
Sacramento, California, United States
Aurora, Colorado, United States
Atlanta, Georgia, United States
Chicago, Illinois, United States
Indianapolis, Indiana, United States
Boston, Massachusetts, United States
Ann Arbor, Michigan, United States
Lansing, Michigan, United States
Minneapolis, Minnesota, United States
Rochester, Minnesota, United States
Saint Paul, Minnesota, United States
Kansas City, Missouri, United States
Paterson, New Jersey, United States
Valley Stream, New York, United States
Chapel Hill, North Carolina, United States
Durham, North Carolina, United States
Portland, Oregon, United States
Nashville, Tennessee, United States
Dallas, Texas, United States
Houston, Texas, United States
Salt Lake City, Utah, United States
Seattle, Washington, United States